| Dr Jessie L Wheeler, DC | |
|
809 S 1st St, Hamilton, MT 59840-3015 | |
| (406) 961-9022 | |
| Not Available |
| Full Name | Dr Jessie L Wheeler |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 14 Years |
| Location | 809 S 1st St, Hamilton, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871891242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1253 (Montana) | Primary |
| Provider Name | Balanced Wellness Chiropractic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508161290 PECOS PAC ID: 7911182365 Enrollment ID: O20110428000210 |
News Archive
Researchers at Montclair State University and Kessler Foundation received a three-year $456,710 grant from the New Jersey Commission on Brain Injury Research to develop treatment interventions for the deficits in long-term memory that hinder recovery after traumatic brain injury (TBI).
Ahead of the International AIDS Conference, scheduled to kick off July 18, health experts on Monday called for a rethinking of international drug policies to incorporate greater scientific evidence and increase access to HIV prevention, treatment and care, the Associated Press reports (6/28).
Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
A 5-year study of patients with severe traumatic brain injury conducted at Hennepin County Medical Center in Minneapolis shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism and its ability to recover from injury.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessie L Wheeler, DC 809 S 1st St, Hamilton, MT 59840-3015 Ph: (406) 961-9022 | Dr Jessie L Wheeler, DC 809 S 1st St, Hamilton, MT 59840-3015 Ph: (406) 961-9022 |
News Archive
Researchers at Montclair State University and Kessler Foundation received a three-year $456,710 grant from the New Jersey Commission on Brain Injury Research to develop treatment interventions for the deficits in long-term memory that hinder recovery after traumatic brain injury (TBI).
Ahead of the International AIDS Conference, scheduled to kick off July 18, health experts on Monday called for a rethinking of international drug policies to incorporate greater scientific evidence and increase access to HIV prevention, treatment and care, the Associated Press reports (6/28).
Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
A 5-year study of patients with severe traumatic brain injury conducted at Hennepin County Medical Center in Minneapolis shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism and its ability to recover from injury.
› Verified 7 days ago
Dr. Lucas J Pernsteiner, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 514 N 1st St, Hamilton, MT 59840 Phone: 406-273-0237 | |
Dr. Justin Lee Potts, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 610 N 1st St Ste 4, Hamilton, MT 59840 Phone: 406-361-9232 | |
Dmx Imaging Of Montana Chiropractor Medicare: Medicare Enrolled Practice Location: 803 N 2nd St, Hamilton, MT 59840 Phone: 406-363-2111 Fax: 406-363-0836 | |
Canyon Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 605 S 1st St, Hamilton, MT 59840 Phone: 406-363-3333 | |
Amanda Barnings, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 246 Marcus St, Hamilton, MT 59840 Phone: 406-363-7600 | |
Dr. Janice B Jones, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 246 Marcus St, Hamilton, MT 59840 Phone: 406-363-7600 | |
Potts Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 246 Marcus St, Hamilton, MT 59840 Phone: 406-363-7600 Fax: 406-363-7960 |